Business
Posting of Shareholder Circular
Posting of Shareholder Circular.
About this update from Genedrive Plc
[{"type":"text","content":"\n \nRNS Number : 8101H Genedrive PLC 19 November 2018 \n\n19 November 2018\ngenedrive plc (\"genedrive\" or the \"Company\")\nPosting of Shareholder Circular\ngenedrive plc (AIM: GDR), the near patient molecular diagnostics company, confirms that further to the announcement made on 16 November 2018, a Circular has been published and will be posted to shareholders today in relation to the proposed Placing of 15,217,391 new Ordinary Shares at 23 pence per share raising £3.5 million, the issue of £2.5 million convertible Loan Notes and a broker option of up to £0.5 million through the issue of up to 2,173,913 additional new Ordinary Shares. The circular contains the notice convening the General Meeting to be held at the offices of the Company: The Incubator Building, 48 Grafton Street, Manchester, M13 9XX at 12 noon on 7 December 2018.\nA copy of the Circular will shortly be available on the Company's website at the following URL: www.genedriveplc.com.\n \n- Ends -\nFor further details please contact:\n \n\n\n\ngenedrive plc\nDavid Budd: CEO\nMatthew Fowler: CFO\n\n\n\n\n\n+44 (0)161 989 0245\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP\nJames Steel\nOliver Jackson\n\n\n\n\n\n+44 (0)207 418 8900\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nStanford Capital Partners Limited\nPatrick Claridge\n\n\n\n\n\n+44 (0)203 815 8880\n\n\n\n\nJohn Howes\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConsilium Strategic Communications\nChris Gardner\nMatthew Neal\nLaura Thornton\n\n\n\n\n\n+44 (0) 203 709 5700\[email protected] \n\n\n\n \nNotes to Editors\n \nAbout genedrive\ngenedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® HCV-ID test has received CE-IVD Certification and has been launched in Africa and Asia Pacific. genedrive has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive® platform in the EMEA and SE Asia (ex-India), and with ARKRAY Healthcare pvt Ltd for the distribution of the Genedrive® HCV-ID Kit and Genedrive® platform in India. Further details can be foun...